This account has been removed.
This account has been removed.

ARRY-380, a Selective HER2 Inhibitor: From Drug Design to Clinical Evaluation


Abstract

ARRY-380 has met the original design goal of HER2 selectivity, leading to an acceptable safety profile and preliminary signs of efficacy.
Poster
non-peer-reviewed

ARRY-380, a Selective HER2 Inhibitor: From Drug Design to Clinical Evaluation


Author Information


PDF Share